cp wire

CP Wire Articles

Exelixis and Ipsen Announce Positive CHMP Opinion for Cabometyx in Previously Treated Hepatocellular Carcinoma
  • Exelixis is eligible to receive a milestone payment of $40 million for the approval of the second-line treatment of HCC
  • In May of 2018, the FDA accepted for filiing an sNDA for... read more
Fri, 09/21/18 - 09:42 am
Ex-Novartis Chief Joins uBiome to Help Launch Discovery and Development Business
  • Company expanding into drug discovery, development and commercialization
  • Ubiome also announced it has raised $83 million in Series C financing


uBiome announced on 9/... read more

Fri, 09/21/18 - 09:15 am
MicuRx Recieves Fast Track and QIDP Designations for MRSA Antiobiotics


MicuRx Pharmaceuticals, Inc. announced on 9/21/18 the receipt of the qualified infectious disease product (QIDP) classification and grant of fast track... read more

Fri, 09/21/18 - 09:05 am
Microbiome Report for Week Ending 9/15/18

The Jackson Laboratory and Azitra Receive Department of Defense Grant

... read more

Thu, 09/20/18 - 09:54 am
BeiGene Presents Encouraging Results in Ph I Trial of Tislelizumab in Patients with Microsatellite Instability-High or Mismatch Repair-Deficient Solid Tumors
  • The objective response rate was 29 percent (4 of 22 patients)
  • BeiGene and Celgene Corporation have a global strategic collaboration for the development of tislelizumab in solid tumor... read more
Thu, 09/20/18 - 09:47 am

Pages